The Buck Stops Here: We’re All Responsible for Lp(a) [CE Podcast]

Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials, and the necessity of including diverse participants are described, as well as the importance of keeping Lp(a) front of mind no matter our role as healthcare professionals.

Member Cost: $0 | Non-member Cost: $0
Credits: 0.25 CE contact hours, 0.0 CE pharmacology hours

Course Overview

Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well as the importance of keeping Lp(a) front of mind no matter our role as healthcare professionals.

Earn 0.25 CE contact hours from listening to the podcast episode and completing the course components.

Member Cost: $0 | Non-member Cost: $0
Credits: 0.25 CE contact hours, 0.0 CE pharmacology hours

Register

Learning Objectives

  1. Explain the potential impacts of Lp(a) on the body including the increased risk for stroke and cardiovascular disease
  2. Explain how healthcare professionals can address the need for diversity in clinical trials for Lp(a)
  3. Discuss team-based care strategies to employ to ensure that Lp(a) testing and treatment are front-of-mind for members of the care team

CE certificate available upon successful completion of the post-test and program evaluation.

Register

Faculty

  • Cindy Lamendola, MSN, NP, FAHA, FPCNA
Full_Color_Provider

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.